In colorectal cancer patients receiving chemotherapy, some studies showed a better outcome of 6bp ins > del polymorphism on the survival10, 39, while another report exhibited a higher response rate for patients with TS 6bp ins/ins genotype than those with TS 6bp del/del genotype40. This evidence concerns the gene TYMS and colorectal cancer.